The safety and effectiveness of Ultomiris (ravulizumab-cwvz) as a maintenance therapy for children and adolescents with atypical hemolytic…
Articles by Steve Bryson, PhD
Leakage in an artificial heart valve appeared to trigger atypical hemolytic uremic syndrome (aHUS) in a 70-year-old woman who…
Researchers reported that atypical hemolytic uremic syndrome (aHUS) is driven by abnormal activation of the alternative complement…
Two infections — influenza followed by COVID-19 — were trigger events for separate episodes of atypical hemolytic uremic syndrome…
For this year’s aHUS Awareness Day — held annually on Sept. 24 — advocates worldwide will focus on managing the…
Adults with atypical hemolytic uremic syndrome (aHUS) who start Soliris (eculizumab) within seven days after their symptoms start…
A previously healthy 20-year-old woman developed atypical hemolytic uremic syndrome (aHUS) after having surgery to remove her gallbladder shortly…
A 60-year-old man with atypical hemolytic uremic syndrome (aHUS) was successfully treated with Soliris (eculizumab) using a personalized…
At the onset of atypical hemolytic uremic syndrome (aHUS) among children in India, high levels of antibodies against a…
A COVID-19 vaccine may have triggered the development of two autoimmune diseases, atypical hemolytic uremic syndrome (aHUS) and antineutrophil…